Phase Ib Study of Efsubaglutide Alfa Injection in Obese Adolescents

NCT07693426 · clinicaltrials.gov ↗

PHASE1

Phase

RECRUITING

Status

36

Enrollment

OTHER

Sponsor class

Conditions

Adolescence Obesity

Interventions

DRUG: Efsubaglutide Alfa 5 mg QW
DRUG: Efsubaglutide Alfa 10 mg QW
DRUG: Efsubaglutide Alfa 20 mg QW
DRUG: Efsubaglutide Alfa placebo

Sponsor

Shanghai Yinnuo Pharmaceutical Technology Co., Ltd.